Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
3.
Sci Adv ; 8(49): eabq8437, 2022 12 09.
Article in English | MEDLINE | ID: mdl-36490346

ABSTRACT

Dysregulation of kinase signaling pathways favors tumor cell survival and therapy resistance in cancer. Here, we reveal a posttranslational regulation of kinase signaling and nuclear receptor activity via deubiquitination in T cell acute lymphoblastic leukemia (T-ALL). We observed that the ubiquitin-specific protease 11 (USP11) is highly expressed and associates with poor prognosis in T-ALL. USP11 ablation inhibits leukemia progression in vivo, sparing normal hematopoiesis. USP11 forms a complex with USP7 to deubiquitinate the oncogenic lymphocyte cell-specific protein-tyrosine kinase (LCK) and enhance its activity. Impairment of LCK activity leads to increased glucocorticoid receptor (GR) expression and glucocorticoids sensitivity. Genetic knockout of USP7 improved the antileukemic efficacy of glucocorticoids in vivo. The transcriptional activation of GR target genes is orchestrated by the deubiquitinase activity and mediated via an increase in enhancer-promoter interaction intensity. Our data unveil how dysregulated deubiquitination controls leukemia survival and drug resistance, suggesting previously unidentified therapeutic combinations toward targeting leukemia.


Subject(s)
Precursor Cell Lymphoblastic Leukemia-Lymphoma , Humans , Cell Line, Tumor , Glucocorticoids/pharmacology , Glucocorticoids/therapeutic use , Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/metabolism , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Receptors, Glucocorticoid/metabolism , Signal Transduction , Thiolester Hydrolases/metabolism , Thiolester Hydrolases/therapeutic use , Ubiquitin-Specific Peptidase 7/metabolism
4.
Sci Rep ; 11(1): 14454, 2021 07 14.
Article in English | MEDLINE | ID: mdl-34262099

ABSTRACT

MYCN is an oncogenic driver in neural crest-derived neuroblastoma and medulloblastoma. To better understand the early effects of MYCN activation in a neural-crest lineage context, we profiled the transcriptome of immortalized human retina pigment epithelial cells with inducible MYCN activation. Gene signatures associated with elevated MYC/MYCN activity were induced after 24 h of MYCN activation, which attenuated but sustained at later time points. Unexpectedly, MYCN activation was accompanied by reduced cell growth. Gene set enrichment analysis revealed a senescence-like signature with strong induction of p53 and p21 but in the absence of canonical hallmarks of senescence such as ß-galactosidase positivity, suggesting incomplete cell fate commitment. When scrutinizing the putative drivers of this growth attenuation, differential gene expression analysis identified several regulators of nucleolar stress. This process was also reflected by phenotypic correlates such as cytoplasmic granule accrual and nucleolar coalescence. Hence, we propose that the induction of MYCN congests the translational machinery, causing nucleolar stress and driving cells into a transient pre-senescent state. Our findings shed new light on the early events induced by MYCN activation and may help unravelling which factors are required for cells to tolerate unscheduled MYCN overexpression during early malignant transformation.


Subject(s)
N-Myc Proto-Oncogene Protein , Neuroblastoma , Cell Cycle , Cell Differentiation , Cell Line, Tumor , Cell Proliferation , Humans , Neural Crest/metabolism , Proto-Oncogene Proteins c-myc
5.
Sci Rep ; 8(1): 7642, 2018 05 16.
Article in English | MEDLINE | ID: mdl-29769563

ABSTRACT

Reverse transcription quantitative PCR (RT-qPCR) is the gold standard method for gene expression analysis on mRNA level. To remove experimental variation, expression levels of the gene of interest are typically normalized to the expression level of stably expressed endogenous reference genes. Identifying suitable reference genes and determining the optimal number of reference genes should precede each quantification study. Popular reference genes are not necessarily stably expressed in the examined conditions, possibly leading to inaccurate results. Stably and universally expressed repetitive elements (ERE) have previously been shown to be an excellent alternative for normalization using classic reference genes in human and zebrafish samples. Here, we confirm that in mouse tissues, EREs are broadly applicable reference targets for RT-qPCR normalization, provided that the RNA samples undergo a thorough DNase treatment. We identified Orr1a0, Rltr2aiap, and Rltr13a3 as the most stably expressed mouse EREs across six different experimental conditions. Therefore, we propose this set of ERE reference targets as good candidates for normalization of RT-qPCR data in a plethora of conditions. The identification of widely applicable stable mouse RT-qPCR reference targets for normalization has great potential to facilitate future murine gene expression studies and improve the validity of RT-qPCR data.


Subject(s)
Cardiovascular Abnormalities/genetics , Leukemia, Prolymphocytic, T-Cell/genetics , Neuroblastoma/genetics , Repetitive Sequences, Nucleic Acid/genetics , Reverse Transcriptase Polymerase Chain Reaction/standards , Skin Diseases/genetics , Animals , Cardiovascular Abnormalities/pathology , Disease Models, Animal , Female , Humans , Leukemia, Prolymphocytic, T-Cell/pathology , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neuroblastoma/pathology , Reference Standards , Reverse Transcriptase Polymerase Chain Reaction/methods , Skin Diseases/pathology , Zebrafish/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL